Sabinsa introduces new cosmeceutical ingredient LactoSporin

April 10, 2019

Sabinsa Corp. (East Windsor, NJ) has introduced a postbiotic cosmeceutical ingredient called LactoSporin, which the firm says has antimicrobial, antioxidant, anti-inflammatory, and anti-collagenase properties.

Sabinsa Corp. (East Windsor, NJ) has introduced a postbiotic cosmeceutical ingredient called LactoSporin, which the firm says has antimicrobial, antioxidant, anti-inflammatory, and anti-collagenase properties. Sabinsa also states that the ingredient has shown efficacy for protection against UV radiation, environmental pollutants, skin aging, the prevention of microbial biofilm formation, and inducing hair growth.

LactoSporin is a non-living microbial cell product (postbiotic), that is purified from the culture supernant of the probiotic strain B. coagulans MTCC 5856 (LactoSpore) through a patented process. In vitro studies, conducted by Sabinsa show that the ingredient is highly active against skin pathogens such as Staphylococcus aureus, Streptococcus epidermis, acne causing bacterium Propionibacterium acne, as well as against an opportunistic pathogen Pseudomonas aeruginosa.

LactoSporin is a pale to yellow-brown colored liquid that is completely soluble in water, stable in acidic conditions, and show thermal stability at 90 degrees Celsius for 30 minutes. It is non-mutagenic, and not a dermal or ocular irritant. The ingredient is protected by 12 patents, including in the U.S., Japan, South Korea, Australia, New Zealand, Russia, Europe, Canada, and China.